Here is a very recent discussion between some highly regarded individuals within the ophthalmology space regarding the benefits of combining canaloplasty with a stent -- meaning that EYE may not necessarily have to compete with Glaukos and instead, will benefit from the success of iStent
Viscodilation in the Canal - Eyetube
Nova Eye Medical (EYE) Discussion, page-3
-
- There are more pages in this discussion • 3,185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.5¢ | 17.5¢ | $18.60K | 102.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21284 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 75284 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |